This panel will explore how infectious disease impedes economic growth in developing countries. Panelists will discuss the social and economic impact of HIV/AIDS, TB, and Malaria on developing countries and prospects for lessening the effects of these pathogens.

In response to Global Health challenges, such as HIV/AIDS the public, private and non-governmental organizations have all responded. The debate lies in which sector has responded in the most effective manner. And can often disjoint aid efforts better work together to provide solutions to the health needs of the developing world. Through a discussion of the various types of initiatives from government agencies such as USAID, private multi-nationals such as Merck, and most recently high level non-governmental initiatives such as the Gates Foundation a comparison will be drawn. Which sector is providing the most innovative response? How can the sectors better work together? Through a discussion of the different sector approaches and better opportunities for them to collaborate together a framework of best practices and successful strategies for future collaboration will emerge.

The goal of this panel is to discuss and detail challenges faced by healthcare practitioners in the developing world. Panel will cover specific challenge of accessing, and providing all types of healthcare to women: issues include lack of resources, no funding, uncooperative governments, cultural issues, and mental health post conflict.

One of the most pressing health challenges is making drugs affordable for the developing world, where they are desperately needed. However, without adequate healthcare infrastructure and stable governments that can enforce protection of intellectual property rights how can major pharmaceutical companies make enough profit to sustain drug research and delivery? This panel aims to bring together leaders in various industries and sectors to discuss strategies that can help address this global health concern.